Briefs: Lyfius Pharma and Aurobindo Pharma
News

Briefs: Lyfius Pharma and Aurobindo Pharma

Lyfius Pharma restarts operations at Penicillin-G manufacturing facility

  • By IPP Bureau | July 01, 2025

Lyfius Pharma restarts operations at Penicillin-G manufacturing facility

Lyfius Pharma Private Limited (Lyfius), a wholly owned stepdown subsidiary of Aurobindo Pharma Ltd, has re-started the production, with immediate effect, after receiving the 'consent to operate (CTO) from Andhra Pradesh Pollution Control Board (APPCB) for its Penicillin-G manufacturing facility, at Kakinada, Andhra Pradesh today, June 29, 2025.

Aurobindo Pharma to invest in Swarnaakshu Solar Power

Aurobindo Pharma Ltd had earlier announced that it would enter into a captive solar power purchase agreement and acquire upto 26% stake in Swarnaakshu Solar Power Private Limited ("Swarnaakshu") by June 30, 2025. Pending receipt of state government approval for setting up a captive solar power plant, the required investment for acquiring 26% in Swarnaakshu will be completed on or before September 30, 2025, subject to the receipt of approval from the concerned state government.

Other Related stories

Startup

Digitization

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International